SCHEMBL26063155

SCHEMBL26063155

C=C(C)C(=O)OC(CCCCC)n1c(-c2ccccc2)cc(=O)[nH]c1=S

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
CNR2 P34972 3/20 0.32
ASAH1 Q13510 2/20 0.31
CHRM2 P08172 3/20 0.31
CHRM4 P08173 3/20 0.31
CHRM5 P08912 3/20 0.31
CHRM1 P11229 3/20 0.31
CHRM3 P20309 3/20 0.31
SMPD1 P17405 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
RECQL P46063 1/20 0.31
KMT2A Q03164 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26063149 0.77 ASAH1 (0.42) ALDH1A1CNR2ASAH1CHRM2CHRM4
SCHEMBL26063139 0.77 ALDH1A1 (0.34) ALDH1A1TSHR
SCHEMBL26063142 0.76 CYP2C19 (0.35) ALDH1A1LMNATSHRMEN1KMT2A
SCHEMBL26039901 0.75 MPO (0.36) ALDH1A1KDM4ELMNANPC1RAB9A
SCHEMBL16694192 0.72 TSHR (0.42) ALDH1A1LMNATSHRMAPT
SCHEMBL28294395 0.72 TSHR (0.38) ALDH1A1TSHRMEN1KMT2AGAA
SCHEMBL26034731 0.72 MTNR1A (0.40) ALDH1A1KDM4ETSHRNPC1RAB9A
SCHEMBL26063145 0.71 MMP2 (0.34) ALDH1A1TSHR
SCHEMBL26063163 0.69 CYP2C19 (0.38) ALDH1A1LMNATSHRMEN1KMT2A
SCHEMBL26063228 0.69 LPO (0.32) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230273456-A1 OPTICALLY ACTIVE DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230273456-A1 OPTICALLY ACTIVE DEVICES PDE6C, PDE6D, PDE6A ALDH1A1 277/4885KDM4E 3198/4885LMNA 1560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.